Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
18 Aprile 2024 - 10:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced it will report financial results for the
first quarter 2024 after market close on Thursday, May 9, 2024.
Company management will webcast a corresponding conference call
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.guardanthealth.com. The
webcast will be archived and available for replay after the
event.
About Guardant Health
Guardant Health is a leading precision medicine company focused
on guarding wellness and giving every person more time free from
cancer. Founded in 2012, Guardant is transforming patient care by
providing critical insights into what drives disease through its
advanced blood and tissue tests, real-world data and AI analytics.
Guardant tests help improve outcomes across all stages of care,
including screening to find cancer early, monitoring for recurrence
in early-stage cancer, and helping doctors select the best
treatment for patients with advanced cancer. For more information,
visit guardanthealth.com and follow the company on LinkedIn, X
(Twitter) and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240418783899/en/
Investor Contact: investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Grafico Azioni Guardant Health (NASDAQ:GH)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Guardant Health (NASDAQ:GH)
Storico
Da Mag 2023 a Mag 2024